Biotech Values

[25 Kilos of Gold]

We will know in 4-6 weeks. Their antibiotic trial is against Daptomycin by Cubist. They went against the best in the field. If the trial failed CTIX will be a laughingstock with that PR and it would diminish the other group of impressive drugs in their pipelines.
I don't see management putting that much on the line without a hint on the results. They are running multiple trials at world class facilities, mostly at the medical centers cost.
In a matter of weeks I will know if the PR was fluff or a rare opportunity to be holding a stock before it becomes a Juggernaut.
Have a great weekend ronpopeil